Dyslipidaemia after switch to tenofovir alafenamide (TAF)‐based cART regimens in a cohort of HIV‐positive patients: what clinical relevance?
Author:
Affiliation:
1. Department of Health Sciences Clinic of Infectious Diseases ‘San Paolo’ Hospital University of Milan Milan Italy
2. Pharmacy Unit ASST Santi Paolo e Carlo University of Milan Milan Italy
Publisher
Wiley
Subject
Pharmacology (medical),Infectious Diseases,Health Policy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.12984
Reference16 articles.
1. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV
2. Lipid changes in patients initiating efavirenz‐ and indinavir‐based antiretroviral regimens;Tashima KT;HIV Clin Trials,2003
3. Effects of Protease Inhibitors on Hyperglycemia, Hyperlipidemia, and Lipodystrophy
4. Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects
5. Prevalence, risk factors, and pathophysiology of dysglycemia among people living with HIV in Sub‐Saharan Africa;Njuguna B;J Diabetes Res,2018
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparative Metabolic Effects of Integrase Inhibitor and Emtricitabine-Containing Tenofovir Derivatives in People Living with HIV: A Multi-Center Retrospective Analysis;2024-08-09
2. Comparison of Switching Between Antiretroviral Agents Versus Introducing Lipid-lowering Agents for HAART-induced Dyslipidemia;Clinical Therapeutics;2024-06
3. Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH);Infectious Disease Reports;2023-12-11
4. Reasons, safety and efficacy analysis for conversion of HAART to TAF/FTC/BIC among HIV-infected patients;Chinese Medical Journal;2023-11-29
5. Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks;Alimentary Pharmacology & Therapeutics;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3